Genentech collaboration supports Duality Biotherapeutics' DUPAC platform confidence.
1 report, 1 independent
Updated Sep 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Genentech collaboration supports Duality Biotherapeutics' DUPAC platform confidence.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Hoffmann-La Roche
Swiss healthcare company
Related events
- Earendil Labs collaborates with Genentech.
- BioNTech is listed on Nasdaq and is advancing pancreatic cancer trials using Roche's Tecentriq, while also partnering with Genentech.
- BioNTech pulled the plug on the Phase 2 clinical trial involving Hoffmann-La Roche.
- Hoffmann-La Roche collaborates with Singaporean institutions, including NUS and NRF, on genomic profiling research to accelerate precision medicine.